Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

NCT03013712 is registered in ClinicalTrials.gov with First Affiliated Hospital of Chengdu Medical College as lead sponsor.

NCT NCT03013712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03013712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
Lead sponsor
First Affiliated Hospital of Chengdu Medical College
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2020
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, esophageal carcinoma, gastric cancer, hepatic carcinoma, pancreatic cancer, prostate cancer